Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal

IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion

(2012) Min Feng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Regulatory T cells increase in breast cancer and in stage IV breast cancer

(2011) Zhi-kuan Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The role of JNK in the development of hepatocellular carcinoma

(2011) Madhumita Das et al.   GENES & DEVELOPMENT

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

(2011) Yue-Lei Chen et al.   HEPATOLOGY

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3

(2011) Runqiu Jiang et al.   HEPATOLOGY

Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury

(2011) Min Feng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients

(2010) Ingrid M.E. Desar et al.   INTERNATIONAL JOURNAL OF CANCER

Role of SMAD and Non-SMAD Signals in the Development of Th17 and Regulatory T Cells

(2010) L. Lu et al.   JOURNAL OF IMMUNOLOGY

Depletion of CD4+CD25+regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model

(2009) H. Hong et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Synergistic effect of TGF-β superfamily members on the induction of Foxp3+ Treg

(2009) Ling Lu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Apoptosis of CD4+CD25high T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2

(2008) Kerrington R. Molhoek et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

(2008) Giuseppe Perrone et al.   EUROPEAN JOURNAL OF CANCER

B-Raf-mediated signaling pathway regulates T cell development

(2008) Hirotake Tsukamoto et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

(2007) Klaus Juergen Schmitz et al.   JOURNAL OF HEPATOLOGY